Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy
Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
ASCO 2024: Highlights and analysis
Inavolisib, palbociclib, fulvestrant combo shows sustained benefit beyond disease progression in HER2‑negative metastatic breast cancer
Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC
Some advanced epithelial ovarian cancer patients can avoid a lymphadenectomy without impacting survival outcomes
Monitoring ovarian function in oncology studies
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours
Cancer care in Needle Hospital, Hargeisa, Somaliland
Relapsed refractory multiple myeloma